An Intervention to Improve the Experience of Patients in Intermediate and Long-term Care Units
Study on the Impact of an Intervention to Improve the Experience of Patients Admitted to Intermediate and Long-term Care Units
The goal of this clinical trial is to learn if an intervention that detects and addresses the problems perceived by patients during their hospital stay can improve trust in the hospital among older patients admitted to intermediate and long-term care units. The main questions it aims to answer are:
- Does the intervention increase patients' trust in the hospital, measured as their likelihood of recommending it?
- Does the intervention reduce formal complaints, improve patients' emotional well-being, and improve the job satisfaction of nursing staff? Researchers will compare patients admitted before the intervention was introduced with patients admitted one year after it was introduced to see if trust in the hospital improves.
Participants will:
- Complete, after one month of admission, the hospital's satisfaction questionnaire (which includes the trust question) and a short emotional well-being questionnaire, either themselves or through a relative or caregiver
- In the post-intervention period, be interviewed between days 10 and 15 of admission about the negative aspects of their stay; the results are discussed at multidisciplinary team meetings, where corrective actions are agreed Nursing staff and nursing assistants on the participating wards will complete a job satisfaction questionnaire before and after the intervention.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
This is a quasi-experimental before-and-after study. The primary outcome will be collected cross-sectionally from all eligible patients admitted at a given time before the intervention is implemented, and again from eligible patients admitted one year after implementation. Formal complaints will be collected retrospectively for the year before the intervention and for the intervention year. Patient questionnaires will be completed on paper without personal information and returned in a sealed envelope identified only by a participant code; the envelopes will be opened by independent research staff, and analysts will be blinded to the study period.
The primary analysis will compare the primary outcome between the pre- and post-intervention groups using a superiority approach, with parametric or non-parametric tests as appropriate and multivariable adjustment for potential confounders that differ between periods. Subgroup analyses by type of ward (conventional vs psychogeriatric) are planned. With 93 patients per group, the study has more than 80% power (two-sided alpha 0.05) to detect an increase in the proportion of patients with trust in the institution (score above 7) from 30% to 50%.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Noemí Casaponsa
- Numero di telefono: 43197 0034938960025
- Email: recerca@csapg.cat
Luoghi di studio
-
-
Barcelona
-
Vilanova i la Geltrú, Barcelona, Spagna
- Reclutamento
- Hospital Sant Antoni Abat-Consorci Sanitari Alt Penedès-Garraf
-
Contatto:
- Noemí Casaponsa
- Numero di telefono: 43197 0034938960025
- Email: recerca@csapg.cat
-
Investigatore principale:
- Helena Camell
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Patients admitted to intermediate and long-term care units
Descrizione
Inclusion Criteria:
- Admitted to an intermediate or long-term care unit of Hospital Sant Antoni Abat
- Length of stay of at least 1 month
- Patient and/or caregiver able to take part in the study assessments
- Signed informed consent, given by the patient or by the patient's legal representative
Exclusion Criteria:
- Cognitive or affective disorder that limits the ability to answer the study questionnaires, with no reference person available to answer on the patient's behalf
- Participation in another study involving an experimental intervention during the period of this study and/or with a visit schedule incompatible with this study
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: PROSPECTIVE
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Pre-intervention
Patients admitted to intermediate and long-term care units before the intervention is implemented, receiving usual care |
|
|
Post-intervention
Patients admitted to the same units one year after the intervention is implemented |
Between days 10 and 15 of admission, patients (or their relatives or caregivers) are interviewed following a structured script about the negative aspects they perceive in their hospital stay, including quality of care, comfort, medical information, and assistance with daily activities. Responses are classified using the Net Promoter Score framework. The results are presented at the periodic multidisciplinary team meetings, where a personalized action plan is agreed, documented in the clinical record with assigned responsibilities and deadlines, and reassessed at approximately 30 days. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Trust in the institution
Lasso di tempo: After 1 month of admission, in the pre-intervention group and in the post-intervention group
|
Score on the question "If needed, would you recommend Hospital Sant Antoni Abat?" from the hospital's inpatient satisfaction questionnaire, rated from 0 (would never recommend) to 10 (would actively recommend). Higher scores indicate greater trust. A score above 7 is considered to indicate trust in the institution. |
After 1 month of admission, in the pre-intervention group and in the post-intervention group
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CSAPG-83
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).
Periodo di condivisione IPD
After publication of main results of the study
Criteri di accesso alla condivisione IPD
IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .